A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis
Clinical trial NCT04322708 · COMPLETED
Trial details
- NCT number
- NCT04322708
- Sponsor
- Allakos Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2021-06-04
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.